News
Treatment for cause of sudden sight loss now available through the NHS in England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...
National dementia guidelines updated thanks to Moorfields-led initiative
The National Institute for Health and Care Excellence (NICE) has today updated its national dementia guidance to recommend that all patients newly diagnosed with dementia are offered an eye health assessment with an optometrist. Previously, patients diagnosed with dementia were...
MicroPulse Transscleral Laser Therapy: A Prospective UK Study
Register now to participate. Eagerly anticipated and now underway – a landmark UK medical research study on MicroPulse® Transscleral Laser Therapy (MPTLT) for the treatment of glaucoma using Iridex’ Cyclo G6® Laser and the MicroPulse P3® Delivery Device. A NICE-compliant...
Dr Paul Singh and Prof Gus Gazzard on laser as first line therapy
Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.
